NDC 17856-0138-04 - Lidocaine hydrochloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 17856-0138
- Requested NDC
- 17856-0138-04
- Package NDCs from labels
- 17856-0138-3, 17856-0138-1, 17856-0138-4, 17856-0138-2, 17856-0138-6, 17856-0138-5, 17856-0138-04
- Manufacturer
- ATLANTIC BIOLOGICALS CORP.
- Effective date
- 2025-05-12
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Lidocaine Hydrochloride Oral Topical Solution USP, 2% (Viscous) | ATLANTIC BIOLOGICALS CORP. | 2025-05-12 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 17856-0138-1 | Lidocaine hydrochloride | 50 in 1 BOX, UNIT-DOSE | SOLUTION | 50 | 3 | |
| 17856-0138-2 | Lidocaine hydrochloride | 50 in 1 BOX, UNIT-DOSE | SOLUTION | 50 | 3 | |
| 17856-0138-3 | Lidocaine hydrochloride | 15 mL in 1 CUP, UNIT-DOSE | SOLUTION | 15 | 3 | |
| 17856-0138-4 | Lidocaine hydrochloride | 20 mL in 1 CUP, UNIT-DOSE | SOLUTION | 20 | 3 | |
| 17856-0138-5 | Lidocaine hydrochloride | 72 in 1 BOX, UNIT-DOSE | SOLUTION | 72 | 3 | |
| 17856-0138-6 | Lidocaine hydrochloride | 5 mL in 1 CUP, UNIT-DOSE | SOLUTION | 5 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 17856-0138 | LIDOCAINE HYDROCHLORIDE SOLUTION [ATLANTIC BIOLOGICALS CORP.] | 3 | Current NDC, 6 package rows | 20250514_75d17334-6876-42d0-8a02-82669d139e4f.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 17856-0138-1 | ML - Milliliter | 17856-0138 | c494c261-df59-4696-919e-e062bcc63ab6 | 1 | 2024-03-12 |
| 17856-0138-2 | ML - Milliliter | 17856-0138 | c72c7dce-4880-4309-b60c-c5d0f465dce5 | 1 | 2024-03-12 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Sterile Water | WATER | B. Braun Medical Inc. | f4284eb6-e553-46d4-90d8-efc80a90a480 | 2026-09-18 | Warnings, Adverse reactions | 059QF0KO0R |
| Lidocaine Hydrochloride and Epinephrine | LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE | Hospira, Inc. | 2f94f711-14c4-48ec-c5a3-c5ec4b8e8729 | 2026-09-17 | Warnings, Adverse reactions | V13007Z41A |
| 5Kind Neurophase Pro Pain Relieving | LIDOCAINE HYDROCHLORIDE, MENTHOL | 5KIND TRADING LTD | 72759a1a-6751-4c00-944c-018c2e5f9170 | 2026-09-16 | Warnings | V13007Z41A |
| Dragon Lidocaine Pain | LIDOCAINE HYDROCHLORIDE | Genomma Lab USA | 7f29acd2-a287-4553-a851-c16b183edea6 | 2026-09-16 | Warnings | V13007Z41A |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE ANHYDROUS | Henry Schein, Inc. | 07a2b40b-0386-40d4-b0c4-e69e13610cd9 | 2026-09-14 | Warnings, Adverse reactions | V13007Z41A |
| FlyLeaf RINGWORM TREATMENT | MICONAZOLE NITRATE 2% | Guangzhou Huixue Biotechnology Co., Ltd. | 5b597a3b-b5ff-2246-e063-6394a90a1046 | 2026-09-13 | Warnings | 059QF0KO0R |
| Lidocaine 4% Cream | LIDOCAINE 4% | InvaDerm Corporation | 5b3c6a39-f094-8c2d-e063-6394a90a94c3 | 2026-09-11 | Warnings | V13007Z41A |
| LIDOCAINE HYDROCHLORIDE | LIDOCAINE HYDROCHLORIDE | Henry Schein, Inc. | 23c8f711-e458-479a-9ab0-dcc851311e24 | 2026-09-10 | Warnings, Adverse reactions | V13007Z41A |
| TheraTears | CARBOXYMETHYLCELLULOSE SODIUM | MEDTECH PRODUCTS INC | 17a01236-130f-495b-9f8d-92b6a23b2dc5 | 2026-09-09 | Warnings | K679OBS311 |
| Burn Cream | BENZALKONIUM CHLORIDE, LIDOCAINE HCI | Trifecta Pharmaceuticals USA LLC | e9a9fc7c-31da-ea3f-e053-2a95a90a0eab | 2026-09-09 | Warnings | V13007Z41A |
| Burn Gel | LIDOCAINE HCI | Trifecta Pharmaceuticals USA LLC | e9d3e9be-1036-fad0-e053-2a95a90a6efe | 2026-09-09 | Warnings | V13007Z41A |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | Cardinal Health 107, LLC | 32513e8b-2a81-436e-8da2-439c1dcbf116 | 2026-09-09 | Warnings, Adverse reactions | V13007Z41A |
| American Safety First Aid | LIDOCAINE HCL | Orazen Inc | ea2f776b-dfd0-6ce4-e053-2995a90af009 | 2026-09-07 | Warnings | V13007Z41A |
| MEDI-FIRST Topical Analgesic | LIDOCAINE HCI | Ultra Distributors Inc | b6f288f7-9ae3-215e-e053-2a95a90aedf6 | 2026-09-07 | Warnings | V13007Z41A |
| MEDI-FIRST | BENZALKONIUM CHLORIDE, LIDOCAINE | Orazen Inc | f508434f-5948-7134-e053-2a95a90a03d7 | 2026-09-05 | Warnings | V13007Z41A |
| MEDI-FIRST | BENZALKONIUM CHLORIDE, LIDOCAINE | Orazen Inc | f522fb0b-3d86-b228-e053-2a95a90a55e9 | 2026-09-05 | Warnings | V13007Z41A |
| Nerve Guard Nerve Relief | LIDOCAINE HYDROCHLORIDE, MENTHOL,MAGNESIUM CHLORIDE | Micelle Laboratories, Incorporated | 6b78f40f-2a7f-4c49-96af-1a95acbf430f | 2026-09-04 | Warnings | V13007Z41A |
| Lidocaine Viscous | LIDOCAINE HYDROCHLORIDE | REMEDYREPACK INC. | 6f8d20d2-6a91-4a5b-bfe8-f1baada38442 | 2026-09-03 | Boxed warning, Warnings, Adverse reactions | 1010739 V13007Z41A |
| HUSTLE BUTTER NUMBING | LIDOCAINE HCL, BENZALKONIUM CHLORIDE | H.B.D. DIST. INC. | 5b4d0390-dac6-4a71-9fdc-5c31543e7c5a | 2026-09-02 | Warnings | V13007Z41A |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | PAI Holdings, LLC dba PAI Pharma | 9920daef-b156-4a14-b641-f714191ffb5c | 2026-09-02 | Warnings, Adverse reactions | V13007Z41A |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.